Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea

NCT01215669 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: IDflu™: Split virion inactivated influenza vaccine
BIOLOGICAL: Vaxigrip®: Split virion inactivated influenza vaccine
BIOLOGICAL: IDflu™: Split virion inactivated influenza vaccine
BIOLOGICAL: Vaxigrip®: Split virion inactivated influenza vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company